Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Howell

Showing results (1-10 of 1,117) with videos related to

Pageof 112
Sort By:
Public Health Reports (Washington, D.C. : 1896)|March 27, 2010
Studies of fungus antigens; quantitative studies of cross-reactions between histoplasmin and blastomycin in guinea pigsA HOWELL
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Clarification of anastrozole/megestrol acetate trial program designA Howell
Hormone Research|January 1, 1989
The relationship between age and the effect of adjuvant therapies in women with primary breast cancerA Howell
Tumori|March 29, 2001
[2nd European Breast Cancer Conference, Bruxelles, September 26-30, 2000. Interview with Anthony Howell]A Howell
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Is fulvestrant ("Faslodex") just another selective estrogen receptor modulator?A Howell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2002
Preliminary experience with pure antiestrogensA Howell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2002
Future use of selective estrogen receptor modulators and aromatase inhibitorsA Howell
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Faslodex (ICI 182780). an oestrogen receptor downregulatorA Howell
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
In vitro susceptibility of Actinomyces to terramycinA HOWELL
European Journal of Cancer Care|September 1, 1996
New endocrine treatment strategiesA Howell
Pageof 112

Showing results (1-10 of 1,117) with videos related to

Sort By:
Pageof 112
Public Health Reports (Washington, D.C. : 1896)|March 27, 2010
Studies of fungus antigens; quantitative studies of cross-reactions between histoplasmin and blastomycin in guinea pigsA HOWELL
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Clarification of anastrozole/megestrol acetate trial program designA Howell
Hormone Research|January 1, 1989
The relationship between age and the effect of adjuvant therapies in women with primary breast cancerA Howell
Tumori|March 29, 2001
[2nd European Breast Cancer Conference, Bruxelles, September 26-30, 2000. Interview with Anthony Howell]A Howell
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Is fulvestrant ("Faslodex") just another selective estrogen receptor modulator?A Howell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2002
Preliminary experience with pure antiestrogensA Howell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2002
Future use of selective estrogen receptor modulators and aromatase inhibitorsA Howell
European Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Faslodex (ICI 182780). an oestrogen receptor downregulatorA Howell
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
In vitro susceptibility of Actinomyces to terramycinA HOWELL
European Journal of Cancer Care|September 1, 1996
New endocrine treatment strategiesA Howell
Pageof 112